How Continuous Glucose Monitors Are Becoming Wearable Health Essentials

Lucas and Luna explore how continuous glucose monitors, or CGMs, are crossing over from diabetes management into the general wellness wearable market. They look at the specific case of Dexcom's Stelo sensor, cleared for over-the-counter use in 2024, and what it means for companies like Abbott and Apple. The episode digs into how CGMs work, why non-diabetics are wearing them, and whether the data actually changes behavior or just creates new anxieties. Lucas breaks down the market shift from prescription-only to consumer-friendly devices, the regulatory changes that made it possible, and the open question of whether metabolic monitoring will become as standard as step counting. Luna pushes back on the 'biohacker' framing, wondering if most people even need this data. Together they navigate a fast-moving corner of wearable tech that is quietly reshaping how we think about food, exercise, and metabolic health. #ContinuousGlucoseMonitor #CGM #Dexcom #Stelo #Abbott #Lingo #AppleWatch #WearableTech #HealthTech #MetabolicHealth #BloodSugar #Biohacking #Wellness #SensorTechnology #FDA #DiabetesTech #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo